Pheochromocytoma crisis induced by glucocorticoids: A report of four cases and review of the literature

European Journal of Endocrinology

Volumn 158, Issue 3, 2008, Pages 423-429

  Rosas, Alejandro L ^a   Kasperlik Zaluska, Anna A ^b   Papierska, Lucyna ^b   Bass, Barbara Lee ^a   Pacak, Karel ^c   Eisenhofer, Graeme ^d  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; ADRENALIN; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAMETHASONE; CORTICOTROPIN; DEXAMETHASONE; DOPAMINE; GLUCOCORTICOID; HYDROCORTISONE; METADRENALIN; METHYLPREDNISOLONE; NORADRENALIN; NORMETADRENALIN; PHENOXYBENZAMINE; PREDNISONE; STEROID; VASODILATOR AGENT;

ADRENAL TUMOR; ADRENALECTOMY; ADULT; ANXIETY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE PAIN; BRAIN DISEASE; CARDIOGENIC SHOCK; CARDIOMYOPATHY; CHEST TIGHTNESS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DETERIORATION; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; ELECTROCARDIOGRAM; FEMALE; FOREIGN BODY ASPIRATION; HEART ARREST; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HORMONE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTHERMIA; INTENSIVE CARE; KIDNEY DISEASE; LIVER FAILURE; LUNG EDEMA; MALE; METABOLIC ACIDOSIS; MORBIDITY; MORTALITY; NAUSEA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RESTLESSNESS; RESUSCITATION; SHOCK; SIDE EFFECT; TACHYCARDIA; THORAX PAIN; TUMOR VOLUME; VOMITING; WEAKNESS;

ACUTE DISEASE; ADRENAL GLAND NEOPLASMS; ADULT; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERTENSION; INCIDENTAL FINDINGS; MALE; PHEOCHROMOCYTOMA;

EID: 40949124678     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0778     Document Type: Article

References (27)

1. Browers FM, Lenders JWM, Eisenhofer G & Pacak K. Pheochromocytoma as an Endocrine Emergency. Reviews in Endocrine and Metabolic Disorders, 2003 4 121-128.
2. Sauvage MR, Tulasne PA & Arnaud JP. Hypertensive accident in a surgical patient with unsuspected pheochromocytoma. Anesthesia and Analgesia 1979 36 155-158.
3. Daggett P & Franks S. Steroid responsiveness in pheochromocytoma. BMJ 1977 1 84.
4. Page LB, Raker JW & Berberich FR. Pheochromocytoma with predominant epinephrine secretion. American Journal of Medicine 1969 47 648-652.
5. Kothari SN & Kisken WA. Dexamethasone-induced congestive heart failure in a patient with dilated cardiomyopathy caused by occult pheochromocytoma. Surgery 1998 123 102-105.
6. Manger WM & Gifford RW. Clinical and Experimental Pheochromocytoma, p. 144 Cambridge, MA: Blackwell Science, 1996.
7. Brown H, Goldberg PA, Selter JG, Cabin HS, Marieb NJ, Udelsman R & Setaro JF. Hemorrhagic pheochromocytoma associated with systemic corticosteroid therapy and presenting as myocardial infarction with severe hypertension. Journal of Clinical Endocrinology and Metabolism 2005 90 563-569.
8. Takagi S, Miyazaki S, Fujii T, Daikoku S, Sutani Y, Morii I, Yasuda S, Goto Y & Nonogi H. Dexamethasone-induced cardiogenic shock rescued by percutaneous cardiopulmonary support (PCPS) in a patient with pheochromocytoma. Japanese Circulation Journal 2000 64 785-788.
9. Ehrhart-Bornstein M, Hinson JP, Bornstein S, Scherbaum WA & Vinson GP. Intraadrenal interac-tions in the regulation of adrenocortical steroido-genesis. Endocrine Reviews 1998 19 101-143.
10. Tischler AS, Perlman RL, Mortse GM & Sbeard BE. Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma cell cultures. Journal of Neurochemistry 1983 40 364-370.
11. Udelsman R & Holbrook NJ. Endocrine and molecular responses to surgical stress. Current Problems in Surgery 1994 31 653-720.
12. Wurtman RJ. Control of epinephrine synthesis in the adrenal medulla by the adrenal cortex: hormonal specificity and dose-response curves. Endocrinology 1966 79 608-614.
13. Goodman R, Edgar D, Thocnen H, Wechsler W & Herschman H. Glucocorticoid induction of tyrosine hydroxylase in a continuous cell line of rat pheochromocytoma. Journal of Cell Biology 1978 78 R1-R7.
14. Weiner N & Blaschko H. Adrenal gland endocrinology. In Endocrinology: Adrenal Gland, Eds G Sayers & AD Smith, Washington, DC: American Physiology Society, 1975.
15. Critchley JA, Henderrson CG, Moffat LE, Ungar A, Waite J & West CP. Proceedings: the release of catecholamines from perfused canine adrenal glands by corticoglucocorticoids. Journal of Physiology 1976 254 30P-31P.
16. Shumci Y & Lubo Z. Glucocorticoids and vascular reactivity. Current Vascular Pharmacology 2004 2 1-12.
17. Liu J, Heikkila P, Voutilainen R, Karonen SL & Kahri AI. Pheochromocytoma expressing adrenocor-ticotropin and corticotrophin-releasing h ormone; regulation by glucocorticoids and nerve growth fac-tor. European Journal of Endocrinology 1994 131 221-228.
18. Van Dam PS, Van Gils A, Canninga-van Dijk MR, De Koening EJP, Hofland LJ & De Herder WW. Sequential ACTH and catecholamine secretion in a phaeochromocytoma. European Journal of Endocrinology 2002 147 201-206.
19. Hedeland H, Ostberg G & Hokfelt B. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Medica Scandinavica 1968 184 211-214.
20. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y & Bornstein S. The clinically inapparent adrenal mass: update in diagnosis and management. Endocrine Reviews 2004 25 309-340.
21. Young WF Jr. Management approaches to adrenal incidentalomas: a view from Rochester, Minnesota. Endocrinology and Metabolism Clinics of North America 2000 29 159-185.
22. Kasperlik- Zaluska AA, Roslonowska E Slowinska-Srzednicka J et al. 1111 Patients with adrenal incidentalomas observed at a single endocrinological center: incidence of chromaffin tumors. Annals of New York Academy of Sciences 2006 1073 38-46.
23. Eisenhofer G, Rivers G, Rosas AL, Quezado Z, Manger WM & Pacak K. Adverse drug reactions in patients with phaeochromocytoma: incidence, pre-vention and management. Drug Safety 2007 30 1031-1062.
24. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS & Eisenhofer G. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002 287 1427-1434.
25. Sawka AM, Jaeschke R, Singh RJ & Young WF. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. Journal of Clinical Endocrinology and Metabolism 2003 88 553-558.
26. Bessell-Browne R & O'Malley ME. CT of pheo-chromocytoma and Paraganglioma: risk of adverse reactions with i.v. administration of nonionic con-trast material. American Journal of Roentgenology 2007 188 970-974.
27. Mukherjee JJ, Peppercorn PD, Reznek RH, Patel V, Kallsas G, Besser M & Grossman AB. Pheochromocytoma: effect of nonionic contrast medium in CT on circulating catecholamine levels. Radiology 1997 202 227-231.